Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2004 1
2005 1
2006 1
2008 2
2010 2
2011 6
2012 2
2013 4
2014 2
2015 2
2016 3
2017 2
2018 2
2019 3
2020 1
2021 4
2022 6
2023 2
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

42 results

Results by year

Filters applied: . Clear all
Page 1
Serological response following BNT162b2 anti-SARS-CoV-2 mRNA vaccination in haematopoietic stem cell transplantation patients.
Attolico I, Tarantini F, Carluccio P, Schifone CP, Delia M, Gagliardi VP, Perrone T, Gaudio F, Longo C, Giordano A, Sgherza N, Curci P, Rizzi R, Ricco A, Russo Rossi A, Albano F, Larocca AMV, Vimercati L, Tafuri S, Musto P. Attolico I, et al. Among authors: russo rossi a. Br J Haematol. 2022 Feb;196(4):928-931. doi: 10.1111/bjh.17873. Epub 2021 Oct 18. Br J Haematol. 2022. PMID: 34664267 Free PMC article. No abstract available.
JAK2 V617f in chronic myeloid leukemia: driving force or passive bystander?
Tarantini F, Cumbo C, Zagaria A, Parciante E, Anelli L, Coccaro N, Tota G, Minervini CF, Redavid I, Rossi AR, Conserva MR, Specchia G, Musto P, Albano F. Tarantini F, et al. Among authors: rossi ar. Hematology. 2022 Dec;27(1):842-846. doi: 10.1080/16078454.2022.2108902. Hematology. 2022. PMID: 35938951
SARS-CoV-2 Infection Incidence and Outcome Before and After Full Vaccination in Patients With Monoclonal Gammopathy of Undetermined Significance.
Sgherza N, Di Gennaro D, Curci P, Rizzi R, Roccotelli D, Croce M, Avantaggiato M, Ruga L, Strafella V, Vitucci A, Palma A, Russo Rossi AV, Troiano T, Larocca AMV, Chironna M, Tafuri S, Albano F, Musto P. Sgherza N, et al. Among authors: russo rossi av. Hemasphere. 2022 Nov 9;6(12):e800. doi: 10.1097/HS9.0000000000000800. eCollection 2022 Dec. Hemasphere. 2022. PMID: 36382051 Free PMC article. No abstract available.
Clonal Hematopoiesis at the Crossroads of Inflammatory Bowel Diseases and Hematological Malignancies: A Biological Link?
Cumbo C, Tarantini F, Zagaria A, Anelli L, Minervini CF, Coccaro N, Tota G, Impera L, Parciante E, Conserva MR, Redavid I, Carluccio P, Delia M, Giordano A, Longo MC, Perrone T, Rossi AR, Specchia G, Musto P, Albano F. Cumbo C, et al. Among authors: rossi ar. Front Oncol. 2022 Apr 12;12:873896. doi: 10.3389/fonc.2022.873896. eCollection 2022. Front Oncol. 2022. PMID: 35494055 Free PMC article.
Clonal hematopoiesis onset in chronic myeloid leukemia patients developing an adverse cardiovascular event.
Tarantini F, Cumbo C, Zagaria A, Anelli L, Parciante E, Redavid I, Coccaro N, Tota G, Conserva MR, Minervini CF, Minervini A, Attolico I, Russo Rossi A, Specchia G, Musto P, Albano F. Tarantini F, et al. Among authors: russo rossi a. Leuk Res. 2023 Apr;127:107023. doi: 10.1016/j.leukres.2023.107023. Epub 2023 Jan 24. Leuk Res. 2023. PMID: 36822077
Dasatinib first-line: Multicentric Italian experience outside clinical trials.
Breccia M, Stagno F, Luciano L, Abruzzese E, Annunziata M, D'Adda M, Maggi A, Sgherza N, Russo-Rossi A, Pregno P, Castagnetti F, Iurlo A, Latagliata R, Cedrone M, Di Renzo N, Sorà F, Rege-Cambrin G, La Nasa G, Scortechini AR, Greco G, Franceschini L, Sica S, Bocchia M, Crugnola M, Orlandi E, Guarini A, Specchia G, Rosti G, Saglio G, Alimena G. Breccia M, et al. Among authors: russo rossi a. Leuk Res. 2016 Jan;40:24-9. doi: 10.1016/j.leukres.2015.11.008. Epub 2015 Nov 17. Leuk Res. 2016. PMID: 26643920
Skin lesions in chronic myeloid leukemia patients during dasatinib treatment.
Tarantini F, Anelli L, Ingravallo G, Attolico I, Zagaria A, Russo Rossi A, Lospalluti L, Bufano T, Zanframundo G, Maiorano E, Specchia G, Albano F. Tarantini F, et al. Among authors: russo rossi a. Cancer Manag Res. 2019 Aug 26;11:7991-7996. doi: 10.2147/CMAR.S217872. eCollection 2019. Cancer Manag Res. 2019. PMID: 31692557 Free PMC article.
Pro-Inflammatory and Pro-Oxidative Changes During Nilotinib Treatment in CML Patients: Results of a Prospective Multicenter Front-Line TKIs Study (KIARO Study).
Sicuranza A, Ferrigno I, Abruzzese E, Iurlo A, Galimberti S, Gozzini A, Luciano L, Stagno F, Russo Rossi A, Sgherza N, Cattaneo D, Zuanelli Brambilla C, Marzano C, Fava C, Mulas O, Cencini E, Santoni A, Sammartano V, Gozzetti A, Puccetti L, Bocchia M. Sicuranza A, et al. Among authors: russo rossi a. Front Oncol. 2022 Feb 1;12:835563. doi: 10.3389/fonc.2022.835563. eCollection 2022. Front Oncol. 2022. PMID: 35178353 Free PMC article.
42 results